STLN

SEC source: 0001799191-24-000041 · wk-form4_1732231216.xml · nonDerivative · entry 3

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,968

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.135 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000041 · wk-form4_1732231216.xml · nonDerivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,994

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.135 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000041 · wk-form4_1732231216.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,261

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.135 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001799191-24-000037 · wk-form4_1731974086.xml · nonDerivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,970

F2 · shares: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000037 · wk-form4_1731974086.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,009

F1 · shares: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000035 · wk-form4_1731973928.xml · nonDerivative · entry 2

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,409

F2 · shares: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000035 · wk-form4_1731973928.xml · nonDerivative · entry 1

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,781

F1 · shares: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000033 · wk-form4_1731973827.xml · nonDerivative · entry 2

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 721,711

F2 · acquired: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000033 · wk-form4_1731973827.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 838,853

F1 · acquired: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0001799191-24-000063 · wk-form4_1733173486.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,753

F1 · balance_after: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 and $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.

SEC source: 0000950170-24-098843 · ownership.xml · nonDerivative · entry 2

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 252,626

F2 · kind: Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F2 · price: Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F2 · ownership.nature: Also on August 16, 2024, following the TOI HC 1 Distribution, Havencrest Healthcare Partners, L.P. made a further pro-rata in-kind distribution of the 7,631,418 shares it received in the TOI HC 1 Distribution to its limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 152,626 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

SEC source: 0000950170-24-098843 · ownership.xml · nonDerivative · entry 1

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 7,884,044

F1 · kind: On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC 1 Distribution"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F1 · price: On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC 1 Distribution"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F1 · ownership.nature: On August 16, 2024, TOI HC I, LLC distributed an aggregate of 8,701,823 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC 1 Distribution"). Immediately following the TOI HC 1 Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 7,631,418 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 100,000 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

SEC source: 0001799191-24-000015 · edgardoc.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 676,203

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-24-000013 · edgardoc.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 694,324

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-24-000011 · edgardoc.xml · derivative · entry 3

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496,293

Underlying: Common Stock · 496,293 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000011 · edgardoc.xml · nonDerivative · entry 2

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 916,947

F2 · shares: Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000011 · edgardoc.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 718,430

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

SEC source: 0001799191-24-000010 · edgardoc.xml · derivative · entry 2

Shah Mihir · CIK 0001676960 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,648

Underlying: Common Stock · 378,648 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000010 · edgardoc.xml · nonDerivative · entry 1

Shah Mihir · CIK 0001676960 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,931

F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

F2 · balance_after: Amount includes a reduction of 4,650 shares from the prior filing, as it corrects an inadvertent overstatement of holdings due to clerical error.

SEC source: 0001799191-24-000009 · edgardoc.xml · derivative · entry 2

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,825

Underlying: Common Stock · 43,825 shares

Expires 2034-05-21

F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000009 · edgardoc.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,368

F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000008 · edgardoc.xml · derivative · entry 2

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,299

Underlying: Common Stock · 175,299 shares

Expires 2034-05-21

F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001799191-24-000008 · edgardoc.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,460

F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0000950170-24-009050 · ownership.xml · nonDerivative · entry 1

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.19, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000121 · doc4.xml · nonDerivative · entry 3

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 8,637

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000121 · doc4.xml · nonDerivative · entry 2

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 15,616

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000121 · doc4.xml · nonDerivative · entry 1

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 27,498

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.44, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000108 · doc4.xml · nonDerivative · entry 3

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 52,413

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000108 · doc4.xml · nonDerivative · entry 2

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 57,751

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000899243-24-000108 · doc4.xml · nonDerivative · entry 1

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 68,014

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.19, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F4 · ownership.nature: Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.

SEC source: 0000950170-24-000345 · ownership.xml · nonDerivative · entry 2

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 8,881,823

F2 · kind: Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P. received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P.

F3 · kind: (Continued from footnote 2) Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F2 · price: Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P. received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P.

F3 · price: (Continued from footnote 2) Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F2 · ownership.nature: Also on December 28, 2023, following the TOI HC I Distribution, the General Partner, on behalf of Havencrest Healthcare Partners, L.P., made a further pro-rata in-kind distribution of the 3,999,998 shares Havencrest Healthcare Partners, L.P. received in the TOI HC I Distribution to Havencrest Healthcare Partners, L.P.'s limited partners in accordance with the governing documents of Havencrest Healthcare Partners, L.P. (the "Havencrest LP Distribution"). Immediately following the Havencrest LP Distribution, Havencrest Healthcare Partners GP, LLC was the record holder of 80,000 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P.

F3 · ownership.nature: (Continued from footnote 2) Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

SEC source: 0000950170-24-000345 · ownership.xml · nonDerivative · entry 1

Havencrest Healthcare Partners, L.P. · CIK 0001705748 · 10% owner

Havencrest Healthcare Partners GP, LLC · CIK 0001893722 · 10% owner

TOI HC I, LLC · CIK 0001892154 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 12,801,821

F1 · kind: On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC I Distribution"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F1 · price: On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC I Distribution"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

F1 · ownership.nature: On December 28, 2023, TOI HC I, LLC distributed an aggregate of 4,561,050 shares of the Issuer's common stock in a pro-rata in-kind distribution to its members in accordance with the governing documents of TOI HC I, LLC (the "TOI HC I Distribution"). Immediately following the TOI HC I Distribution, Havencrest Healthcare Partners GP, LLC (the "General Partner") was the record holder of 3,999,998 shares of the Issuer's common stock and TOI HC I, LLC was the record holder of 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.

SEC source: 0001628280-23-042830 · wk-form4_1703804321.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,193

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042820 · wk-form4_1703801773.xml · nonDerivative · entry 1

Ling Gabriel · CIK 0001945281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,057

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042829 · wk-form4_1703803565.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713,850

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042826 · wk-form4_1703803101.xml · nonDerivative · entry 1

Johnson Karen Marie · CIK 0001892819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,185

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042824 · wk-form4_1703802464.xml · nonDerivative · entry 1

Kaushal Mohit · CIK 0001683021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,253

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042818 · wk-form4_1703801197.xml · nonDerivative · entry 1

McGeorge Anne · CIK 0001779934 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,346

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042815 · wk-form4_1703800674.xml · nonDerivative · entry 1

O'Meara Maeve · CIK 0001742487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,104

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-042795 · wk-form4_1703797778.xml · nonDerivative · entry 1

Pacala Mark L · CIK 0001321250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,029

F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

SEC source: 0001628280-23-041777 · wk-form4_1702931201.xml · nonDerivative · entry 2

Shah Mihir · CIK 0001676960 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,122

SEC source: 0001628280-23-041777 · wk-form4_1702931201.xml · nonDerivative · entry 1

Shah Mihir · CIK 0001676960 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,557

SEC source: 0001628280-23-040679 · wk-form4_1701736970.xml · derivative · entry 2

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,849

Underlying: Common stock · 30,849 shares

Expires 2033-11-30

F2 · derivative.exercise_date: The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001628280-23-040679 · wk-form4_1701736970.xml · nonDerivative · entry 1

Castle Jeremy · CIK 0001992507 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,340

F1 · shares: Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 30, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC source: 0001628280-23-039913 · wk-form4_1700704878.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 671,198

SEC source: 0001628280-23-039911 · wk-form4_1700704014.xml · nonDerivative · entry 1

Virnich Daniel · CIK 0001891107 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,603

SEC source: 0001628280-23-039909 · wk-form4_1700703432.xml · nonDerivative · entry 1

Podnos Yale · CIK 0001891104 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,838

SEC source: 0001628280-23-039815 · wk-form4_1700612843.xml · derivative · entry 3

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,745,431

Underlying: Common stock · 25,000 shares

Expires 2029-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.

SEC source: 0001628280-23-039815 · wk-form4_1700612843.xml · nonDerivative · entry 2

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 697,065

SEC source: 0001628280-23-039815 · wk-form4_1700612843.xml · nonDerivative · entry 1

Hively Brad · CIK 0001891124 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 722,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.